ZPW-U:CA:TSX-BMO US Put Write ETF (USD)

ETF | Others |

Last Closing

CAD 15.7

Change

-0.02 (-0.13)%

Market Cap

N/A

Volume

730.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.22 (-0.76%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.37B
XEQT:CA iShares Core Equity Portfolio

-0.20 (-0.62%)

CAD 4.78B
PHYS-U:CA Sprott Physical Gold Trust

+0.26 (+1.28%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.29 (-0.80%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.26 (+1.06%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.08 (-0.75%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 2.53B

ETFs Containing ZPW-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.51% 5% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.51% 6% D- 16% F
Trailing 12 Months  
Capital Gain 5.44% 13% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.44% 14% F 20% F
Trailing 5 Years  
Capital Gain -1.75% 21% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.75% 21% F 24% F
Average Annual (5 Year Horizon)  
Capital Gain 0.97% N/A N/A 41% F
Dividend Return 1.23% N/A N/A 33% F
Total Return 0.25% N/A N/A 22% F
Risk Return Profile  
Volatility (Standard Deviation) 10.79% N/A N/A 81% B-
Risk Adjusted Return 11.36% N/A N/A 34% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike